Programmed death-ligand 1 expression in gastric cancer: correlation with mismatch repair deficiency and HER2-negative status-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Programmed death-ligand 1 expression in gastric cancer: correlation with mismatch repair deficiency and HER2-negative status

Published:2018-04-19 Issue:6 Volume:7 Page:2612-2620
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Wang Lei¹²,Zhang Qiongyan¹²^ORCID,Ni Shujuan¹²,Tan Cong¹²,Cai Xu¹²,Huang Dan¹²,Sheng Weiqi¹²

Affiliation:

1. Department of Pathology; Fudan University Shanghai Cancer Center; Shanghai 200032 China

2. Department of Oncology; Shanghai Medical College; Fudan University; Shanghai 200032 China

Funder

Natural Science Foundation of Shanghai

National Natural Science Foundation of China

Shanghai Hospital Development Center

Shanghai Key Developing Disciplines

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Reference34 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015

2. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;Bang;Lancet,2010

3. HER2 status in gastric and gastroesophageal junction cancer assessed by local and central laboratories: Chinese results of the HER-EAGLE study;Huang;PLoS ONE,2013

4. Immune checkpoint blockade: a common denominator approach to cancer therapy;Topalian;Cancer Cell,2015

5. PD-1 blockade induces responses by inhibiting adaptive immune resistance;Tumeh;Nature,2014

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Pembrolizumab as a Salvage Therapy Based on HER2 Expression in Advanced Gastric Cancer;Cancers;2024-08-26

2. HER2 Amplification and PD-L1 Expression in Advanced Gastric Cancer: Correlations, Clinical Implications, and Molecular Characteristics;2024-08-19

3. Three biomarkers (HER2, PD‐L1, and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience;International Journal of Cancer;2024-07-12

4. State of the art: Targeting microsatellite instability in gastrointestinal cancers;Critical Reviews in Oncology/Hematology;2024-07

5. Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical Management;Journal of the National Comprehensive Cancer Network;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3